Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Jamjoom Pharmaceuticals Factory Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jamjoom Pharmaceuticals Factory Co. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Jamjoom Pharmaceuticals Factory Co.
-10.02%
0.59
25.32%
Saudi Arabia All Share TASI
-0.13%
-0.01
13.67%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.76%
EBIT Growth (5y)
22.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.86
Tax Ratio
5.60%
Dividend Payout Ratio
60.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.93%
ROE (avg)
21.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
5.79
EV to EBIT
21.16
EV to EBITDA
19.80
EV to Capital Employed
5.79
EV to Sales
6.62
PEG Ratio
0.75
Dividend Yield
NA
ROCE (Latest)
27.37%
ROE (Latest)
27.03%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SAR 419.78 MM
ROCE(HY)
Highest at 29%
RAW MATERIAL COST(Y)
Fallen by -0.75% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.52 times
NET SALES(Q)
Highest at SAR 481.38 MM
OPERATING PROFIT(Q)
Highest at SAR 188.12 MM
OPERATING PROFIT MARGIN(Q)
Highest at 39.08 %
PRE-TAX PROFIT(Q)
Highest at SAR 176.25 MM
NET PROFIT(Q)
Highest at SAR 171.19 MM
EPS(Q)
Highest at SAR 2.4
-19What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 12,245.55
OPERATING CASH FLOW(Y)
Lowest at SAR 213.27 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.98 times
INTEREST(Q)
Highest at SAR 1.54 MM
Here's what is working for Jamjoom Pharmaceuticals Factory Co.
Operating Cash Flow
Highest at SAR 419.78 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SAR MM)
Net Sales
Highest at SAR 481.38 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (SAR MM)
Operating Profit
Highest at SAR 188.12 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SAR MM)
Operating Profit Margin
Highest at 39.08 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at SAR 176.25 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SAR MM)
Net Profit
Highest at SAR 171.19 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (SAR MM)
EPS
Highest at SAR 2.4
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SAR)
Inventory Turnover Ratio
Highest at 2.52 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -0.75% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at SAR 12.52 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (SAR MM)
Depreciation
At SAR 12.52 MM has Grown at inf%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (SAR MM)
Here's what is not working for Jamjoom Pharmaceuticals Factory Co.
Interest Coverage Ratio
Lowest at 12,245.55 and Fallen
In each period in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
At SAR 1.54 MM has Grown at 443.51%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SAR MM)
Interest Coverage Ratio
Lowest at 12,245.55
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Cash Flow
Lowest at SAR 213.27 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SAR MM)
Interest
Highest at SAR 1.54 MM
in the last five periods and Increased by 443.51% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SAR MM)
Debtors Turnover Ratio
Lowest at 1.98 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
